IKZF1 and T-cell acute lymphoblastic leukemia: Inactivation of IKAROS by a recurrent genetic alteration in the IKZF1 gene is seen in nearly 4–5% of adult and pediatric T- cell Acute Lymphoblastic Leukemia (T-ALL) and is associated with poor outcome [3,4,5,6].